Home › Myositis › Pennsylvania
Myositis clinical trials in Pennsylvania
4 studies for Myositis are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Children's Hospital of Philadelphia - Accepting Young Adult and Juvenile Patients, Philadelphia
- UPMC Children's Hospital of Pittsburgh - Accepting Juvenile Patients, Pittsburgh
- UPMC Arthritis and Autoimmunity Center - Accepting Adult Patients, Pittsburgh
RecruitingPhase 2/3
Ages 6 to 75 · All sexes · Updated Sep 17, 2026 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
- University of Pittsburgh Medical Center: Division of Rheumatology and Clinical Immunology, Pittsburgh
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07103746A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- UPMC Arthritis and Autoimmunity Center, Falk Clinic, Pittsburgh
- UPMC Montefiore Clinical and Translational Research Center (CTRC), Pittsburgh
- UPMC Presbyterian Shadyside Hospital, Pittsburgh
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT05895786A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Jefferson Einstein Hospital Philadelphia, Philadelphia
RecruitingPhase 1
Ages 12 to 70 · All sexes · Updated May 22, 2026 · NCT06308978From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.